Amrutanjan Health Care Reports Strong Nine-Month Profit Growth and Record Sales in March 2025
Amrutanjan Health Care has announced its financial results for the quarter ending March 2025, showcasing stable performance. The company reported a Profit After Tax of Rs 46.23 crore for the nine-month period, reflecting a year-on-year growth of 21.79%, alongside achieving its highest quarterly net sales in five quarters.
Amrutanjan Health Care has recently reported its financial results for the quarter ending March 2025, revealing a stable performance in key metrics. The company's score has undergone an adjustment, reflecting a shift in evaluation over the past three months. In terms of profitability, Amrutanjan Health Care reported a Profit After Tax (PAT) of Rs 46.23 crore for the nine-month period, marking a year-on-year growth of 21.79%. This positive trend in PAT indicates a strong operational performance relative to the previous year. Additionally, the company achieved its highest quarterly net sales in the last five quarters, totaling Rs 135.41 crore, suggesting a robust sales environment.
Furthermore, the PAT for the nine-month period has surpassed the total for the preceding twelve months, indicating that Amrutanjan Health Care has already exceeded its previous sales figures within a shorter timeframe. These developments highlight the company's current operational strengths and market position within the Pharmaceuticals & Biotechnology industry.
For more insights on Amrutanjan Health Care's performance and evaluation changes, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
